Press Release Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval 5 hours ago
Press Release Health Canada Approves Sunshine Biopharma’s Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting Jul 28